Literature DB >> 7803480

Purification and characterization of eukaryotic translational initiation factor eIF-2B from liver.

S R Kimball1, A M Karinch, R C Feldhoff, H Mellor, L S Jefferson.   

Abstract

Eukaryotic initiation factor (eIF)-2B was purified to greater than 95% homogeneity from both rat and bovine liver. The purified protein consisted of five nonidentical subunits with apparent molecular weights ranging from 30.9 to 89.1 kDa. The holoprotein was characterized in terms of its Stokes radius and frictional coefficient. The isoelectric points for the beta-, gamma-, and epsilon-subunits were found to be 6.4, 6.9, and approximately 6.0, respectively; the alpha- and delta-subunits did not focus well because their isoelectric points as predicted by the nucleotide sequences of cDNAs for the two proteins are greater than 8.5. The purified protein was used as antigen to generate monoclonal antibodies to the epsilon-subunit. The eIF-2B epsilon monoclonal antibodies and monoclonal antibodies to the alpha-subunit of eIF-2 were then used to directly quantitate the amounts of eIF-2B and eIF-2 in rat liver and rat reticulocytes. The ratio of eIF-2B to eIF-2 was found to be approx. 0.6 and 0.3 in liver and reticulocytes, respectively, supporting the proposition that phosphorylation of only part of the total cellular eIF-2 could potentially sequester all of the eIF-2B into an inactive eIF-2.eIF-2B complex. The purified protein was also used as substrate in protein kinase assays. Extracts of rat liver were shown to contain protein kinase activity directed toward the epsilon-subunit, but no other subunit of eIF-2B. Overall, the studies presented here are the first to show a direct quantitation of eIF-2 and eIF-2B in different tissues. They also provide evidence that the epsilon-subunit of eIF-2B is the only subunit of eIF-2B that is phosphorylated by protein kinase(s) present in extracts of rat liver.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803480     DOI: 10.1016/0304-4165(94)90079-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids.

Authors:  O J Shah; S R Kimball; L S Jefferson
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

2.  eIF2B, the guanine nucleotide-exchange factor for eukaryotic initiation factor 2. Sequence conservation between the alpha, beta and delta subunits of eIF2B from mammals and yeast.

Authors:  N T Price; H Mellor; B L Craddock; K M Flowers; S R Kimball; T Wilmer; L S Jefferson; C G Proud
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

3.  The Src-family tyrosine kinase inhibitor PP1 interferes with the activation of ribosomal protein S6 kinases.

Authors:  O Jameel Shah; Scot R Kimball; Leonard S Jefferson
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  Cloning of cDNA for the gamma-subunit of mammalian translation initiation factor 2B, the guanine nucleotide-exchange factor for eukaryotic initiation factor 2.

Authors:  N T Price; S R Kimball; L S Jefferson; C G Proud
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

5.  Molecular cloning and characterization of cDNA encoding the alpha subunit of the rat protein synthesis initiation factor eIF-2B.

Authors:  K M Flowers; S R Kimball; R C Feldhoff; A G Hinnebusch; L S Jefferson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice.

Authors:  Peichuan Zhang; Barbara C McGrath; Jamie Reinert; DeAnne S Olsen; Li Lei; Sangeeta Gill; Sheree A Wek; Krishna M Vattem; Ronald C Wek; Scot R Kimball; Leonard S Jefferson; Douglas R Cavener
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

7.  A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells.

Authors:  Liraz Kantor; Dalia Pinchasi; Michelle Mintz; Yetrib Hathout; Adeline Vanderver; Orna Elroy-Stein
Journal:  PLoS One       Date:  2008-11-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.